Long-Term Copaxone(R) Study Showed 92% Of Multiple Sclerosis Patients Were Still Walking Unaided After A Mean Of 10 Years On Treatment

... Data from a 10-yearlong-term study showed that 92 percent of relapsing-remitting multiplesclerosis (RRMS) patients in the study who remained on COPAXONE(R)(glatiramer acetate injection) were still walking without assistancedespite an average disease duration of more than 15 years. These resultswere published in the June 2006 issue of the journal Multiple Sclerosis,which was mailed today... click link for more info. ...